Roche was given further good news by FDA after receiving a Priority Review for its Lucentis drug – this news …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

